To Kill But Not Be Killed: Controlling the Activity of Mammalian Pore-Forming Proteins.

作者: Patrycja A. Krawczyk , Marco Laub , Patrycja Kozik

DOI: 10.3389/FIMMU.2020.601405

关键词:

摘要: Pore-forming proteins (PFPs) are present in all domains of life, and play an important role host-pathogen warfare the elimination cancers. They can be employed to deliver specific effectors across membranes, disrupt membrane integrity interfering with cell homeostasis, lyse membranes either destroying intracellular organelles or entire cells. Considering destructive potential PFPs, it is perhaps not surprising that mechanisms controlling their activity remarkably complex, especially multicellular organisms. Mammalian PFPs discovered date include complement attack complex (MAC), perforins, as well gasdermins. While primary function perforin-1 gasdermins eliminate infected cancerous host cells, perforin-2 MAC target pathogens directly. Yet, mammalian principle capable generating pores healthy cells which-if uncontrolled-could have dire, potentially lethal consequences. In this review, we will highlight strategies protect from destruction by endogenous while enabling timely efficient

参考文章(188)
Gregor Anderluh, Matic Kisovec, Nada Kraševec, Robert J. C. Gilbert, Distribution of MACPF/CDC Proteins Sub-cellular biochemistry. ,vol. 80, pp. 7- 30 ,(2014) , 10.1007/978-94-017-8881-6_2
K. Scott Baker, Cynthia A. DeLaat, Michael Steinbuch, Thomas G. Gross, Ralph S. Shapiro, Brett Loechelt, Richard Harris, Alexandra H. Filipovich, Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation Blood. ,vol. 89, pp. 3857- 3863 ,(1997) , 10.1182/BLOOD.V89.10.3857
H Waldmann, S Meri, B P Morgan, M G Olavesen, R H Daniels, P J Lachmann, A Davies, Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology. ,vol. 71, pp. 1- 9 ,(1990)
R G DiScipio, C A Smith, H J Muller-Eberhard, T E Hugli, The activation of human complement component C5 by a fluid phase C5 convertase. Journal of Biological Chemistry. ,vol. 258, pp. 10629- 10636 ,(1983) , 10.1016/S0021-9258(17)44503-0
Vahid Khajoee, Kenji Ihara, Ryutaro Kira, Megumi Takemoto, Hiroyuki Torisu, Yasunari Sakai, Jia Guanjun, Park Myoung Hee, Katsushi Tokunaga, Toshiro Hara, Founder effect of the C9 R95X mutation in Orientals. Human Genetics. ,vol. 112, pp. 244- 248 ,(2003) , 10.1007/S00439-002-0870-8
R. Würzner, Modulation of complement membrane attack by local C7 synthesis. Clinical and Experimental Immunology. ,vol. 121, pp. 8- 10 ,(2000) , 10.1046/J.1365-2249.2000.01263.X
Ilia Voskoboinik, James C. Whisstock, Joseph A. Trapani, Perforin and granzymes: function, dysfunction and human pathology Nature Reviews Immunology. ,vol. 15, pp. 388- 400 ,(2015) , 10.1038/NRI3839
L E French, J Tschopp, A Chonn, S Hertig, Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9. Journal of Immunology. ,vol. 151, pp. 2159- 2165 ,(1993)